nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.243	0.664	CbGbCtD
Solifenacin—CYP3A4—Colchicine—primary biliary cirrhosis	0.123	0.336	CbGbCtD
Solifenacin—Hepatocellular injury—Colchicine—primary biliary cirrhosis	0.0113	0.0183	CcSEcCtD
Solifenacin—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.0109	0.0177	CcSEcCtD
Solifenacin—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.0109	0.0177	CcSEcCtD
Solifenacin—Bladder pain—Colchicine—primary biliary cirrhosis	0.0102	0.0166	CcSEcCtD
Solifenacin—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.00988	0.0161	CcSEcCtD
Solifenacin—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.00988	0.0161	CcSEcCtD
Solifenacin—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00976	0.0159	CcSEcCtD
Solifenacin—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00976	0.0159	CcSEcCtD
Solifenacin—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00914	0.0149	CcSEcCtD
Solifenacin—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00914	0.0149	CcSEcCtD
Solifenacin—Benazepril—ACE—primary biliary cirrhosis	0.00909	1	CrCbGaD
Solifenacin—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00774	0.0126	CcSEcCtD
Solifenacin—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00774	0.0126	CcSEcCtD
Solifenacin—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00771	0.0126	CcSEcCtD
Solifenacin—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00771	0.0126	CcSEcCtD
Solifenacin—Muscular weakness—Colchicine—primary biliary cirrhosis	0.0072	0.0117	CcSEcCtD
Solifenacin—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00678	0.011	CcSEcCtD
Solifenacin—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00678	0.011	CcSEcCtD
Solifenacin—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.0067	0.0109	CcSEcCtD
Solifenacin—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.0067	0.0109	CcSEcCtD
Solifenacin—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00634	0.0103	CcSEcCtD
Solifenacin—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00634	0.0103	CcSEcCtD
Solifenacin—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00593	0.00966	CcSEcCtD
Solifenacin—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00593	0.00966	CcSEcCtD
Solifenacin—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00921	CcSEcCtD
Solifenacin—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00921	CcSEcCtD
Solifenacin—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00921	CcSEcCtD
Solifenacin—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00921	CcSEcCtD
Solifenacin—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00564	0.00918	CcSEcCtD
Solifenacin—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00564	0.00918	CcSEcCtD
Solifenacin—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00556	0.00905	CcSEcCtD
Solifenacin—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00556	0.00905	CcSEcCtD
Solifenacin—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0055	0.00895	CcSEcCtD
Solifenacin—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0055	0.00895	CcSEcCtD
Solifenacin—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00535	0.00871	CcSEcCtD
Solifenacin—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00535	0.00871	CcSEcCtD
Solifenacin—Eye disorder—Colchicine—primary biliary cirrhosis	0.00528	0.0086	CcSEcCtD
Solifenacin—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00509	0.00829	CcSEcCtD
Solifenacin—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00504	0.00821	CcSEcCtD
Solifenacin—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00504	0.00821	CcSEcCtD
Solifenacin—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00501	0.00817	CcSEcCtD
Solifenacin—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00501	0.00817	CcSEcCtD
Solifenacin—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.005	0.00815	CcSEcCtD
Solifenacin—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.005	0.00815	CcSEcCtD
Solifenacin—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00499	0.00813	CcSEcCtD
Solifenacin—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00499	0.00813	CcSEcCtD
Solifenacin—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00498	0.00811	CcSEcCtD
Solifenacin—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00498	0.00811	CcSEcCtD
Solifenacin—Malnutrition—Colchicine—primary biliary cirrhosis	0.00492	0.00801	CcSEcCtD
Solifenacin—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00474	0.00773	CcSEcCtD
Solifenacin—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00474	0.00773	CcSEcCtD
Solifenacin—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00471	0.00767	CcSEcCtD
Solifenacin—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00471	0.00767	CcSEcCtD
Solifenacin—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00461	0.0075	CcSEcCtD
Solifenacin—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00461	0.0075	CcSEcCtD
Solifenacin—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00459	0.00747	CcSEcCtD
Solifenacin—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00459	0.00747	CcSEcCtD
Solifenacin—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00458	0.00745	CcSEcCtD
Solifenacin—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00458	0.00745	CcSEcCtD
Solifenacin—Angioedema—Colchicine—primary biliary cirrhosis	0.00449	0.00732	CcSEcCtD
Solifenacin—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00442	0.0072	CcSEcCtD
Solifenacin—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00442	0.0072	CcSEcCtD
Solifenacin—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00404	0.00658	CcSEcCtD
Solifenacin—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00404	0.00658	CcSEcCtD
Solifenacin—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00394	0.00641	CcSEcCtD
Solifenacin—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00391	0.00636	CcSEcCtD
Solifenacin—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00391	0.00636	CcSEcCtD
Solifenacin—Skin disorder—Colchicine—primary biliary cirrhosis	0.0039	0.00635	CcSEcCtD
Solifenacin—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00386	0.00628	CcSEcCtD
Solifenacin—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00386	0.00628	CcSEcCtD
Solifenacin—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00382	0.00621	CcSEcCtD
Solifenacin—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00382	0.00621	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00374	0.00609	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00374	0.00609	CcSEcCtD
Solifenacin—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00368	0.00599	CcSEcCtD
Solifenacin—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00368	0.00599	CcSEcCtD
Solifenacin—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00364	0.00592	CcSEcCtD
Solifenacin—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00364	0.00592	CcSEcCtD
Solifenacin—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00358	0.00584	CcSEcCtD
Solifenacin—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00358	0.00584	CcSEcCtD
Solifenacin—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00354	0.00576	CcSEcCtD
Solifenacin—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00354	0.00576	CcSEcCtD
Solifenacin—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00573	CcSEcCtD
Solifenacin—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00573	CcSEcCtD
Solifenacin—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0035	0.00571	CcSEcCtD
Solifenacin—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0035	0.00571	CcSEcCtD
Solifenacin—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00349	0.00568	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00347	0.00564	CcSEcCtD
Solifenacin—Fatigue—Colchicine—primary biliary cirrhosis	0.00346	0.00564	CcSEcCtD
Solifenacin—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00328	0.00535	CcSEcCtD
Solifenacin—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00321	0.00522	CcSEcCtD
Solifenacin—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00321	0.00522	CcSEcCtD
Solifenacin—Urticaria—Colchicine—primary biliary cirrhosis	0.00319	0.00519	CcSEcCtD
Solifenacin—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00517	CcSEcCtD
Solifenacin—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00318	0.00517	CcSEcCtD
Solifenacin—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00317	0.00517	CcSEcCtD
Solifenacin—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00511	CcSEcCtD
Solifenacin—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00511	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00507	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00507	CcSEcCtD
Solifenacin—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00506	CcSEcCtD
Solifenacin—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00311	0.00506	CcSEcCtD
Solifenacin—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00308	0.00502	CcSEcCtD
Solifenacin—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00308	0.00502	CcSEcCtD
Solifenacin—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00484	CcSEcCtD
Solifenacin—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00484	CcSEcCtD
Solifenacin—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00296	0.00482	CcSEcCtD
Solifenacin—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00295	0.0048	CcSEcCtD
Solifenacin—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00295	0.0048	CcSEcCtD
Solifenacin—Asthenia—Colchicine—primary biliary cirrhosis	0.00288	0.00469	CcSEcCtD
Solifenacin—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00467	CcSEcCtD
Solifenacin—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00467	CcSEcCtD
Solifenacin—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00285	0.00464	CcSEcCtD
Solifenacin—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00285	0.00464	CcSEcCtD
Solifenacin—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00266	0.00433	CcSEcCtD
Solifenacin—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00266	0.00433	CcSEcCtD
Solifenacin—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00259	0.00421	CcSEcCtD
Solifenacin—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00259	0.00421	CcSEcCtD
Solifenacin—Vomiting—Colchicine—primary biliary cirrhosis	0.00255	0.00416	CcSEcCtD
Solifenacin—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00416	CcSEcCtD
Solifenacin—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00416	CcSEcCtD
Solifenacin—Rash—Colchicine—primary biliary cirrhosis	0.00253	0.00412	CcSEcCtD
Solifenacin—Dermatitis—Colchicine—primary biliary cirrhosis	0.00253	0.00412	CcSEcCtD
Solifenacin—Headache—Colchicine—primary biliary cirrhosis	0.00252	0.0041	CcSEcCtD
Solifenacin—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00239	0.00388	CcSEcCtD
Solifenacin—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00239	0.00388	CcSEcCtD
Solifenacin—Nausea—Colchicine—primary biliary cirrhosis	0.00238	0.00388	CcSEcCtD
Solifenacin—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00374	CcSEcCtD
Solifenacin—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00374	CcSEcCtD
Solifenacin—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.0037	CcSEcCtD
Solifenacin—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.0037	CcSEcCtD
Solifenacin—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.0037	CcSEcCtD
Solifenacin—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.0037	CcSEcCtD
Solifenacin—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00226	0.00368	CcSEcCtD
Solifenacin—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00226	0.00368	CcSEcCtD
Solifenacin—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00214	0.00349	CcSEcCtD
Solifenacin—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00214	0.00349	CcSEcCtD
Solifenacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000128	0.012	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000126	0.0117	CbGpPWpGaD
Solifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000122	0.0114	CbGpPWpGaD
Solifenacin—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000122	0.0113	CbGpPWpGaD
Solifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000118	0.011	CbGpPWpGaD
Solifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000118	0.011	CbGpPWpGaD
Solifenacin—CHRM4—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000117	0.0109	CbGpPWpGaD
Solifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000117	0.0109	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.000114	0.0107	CbGpPWpGaD
Solifenacin—CHRM5—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000112	0.0104	CbGpPWpGaD
Solifenacin—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000108	0.0101	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.0001	0.00933	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	9.59e-05	0.00893	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	9.55e-05	0.0089	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	9.09e-05	0.00847	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	8.71e-05	0.00811	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	8.38e-05	0.00781	CbGpPWpGaD
Solifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	7.88e-05	0.00734	CbGpPWpGaD
Solifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	7.86e-05	0.00732	CbGpPWpGaD
Solifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	7.78e-05	0.00725	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CXCR5—primary biliary cirrhosis	7.63e-05	0.0071	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	7.61e-05	0.00709	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CXCR5—primary biliary cirrhosis	7.3e-05	0.0068	CbGpPWpGaD
Solifenacin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	7.13e-05	0.00664	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CXCL9—primary biliary cirrhosis	6.92e-05	0.00645	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	6.75e-05	0.00629	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	6.73e-05	0.00627	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	6.66e-05	0.00621	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CXCL9—primary biliary cirrhosis	6.63e-05	0.00618	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	6.13e-05	0.00571	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	6.11e-05	0.00569	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	6.05e-05	0.00564	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	5.96e-05	0.00555	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	5.59e-05	0.0052	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	5.14e-05	0.00479	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	5.13e-05	0.00478	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCR5—primary biliary cirrhosis	5.13e-05	0.00477	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	5.09e-05	0.00474	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	5.08e-05	0.00473	CbGpPWpGaD
Solifenacin—CHRM5—G alpha (q) signalling events—AGT—primary biliary cirrhosis	4.93e-05	0.00459	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	4.74e-05	0.00441	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	4.67e-05	0.00435	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCL9—primary biliary cirrhosis	4.65e-05	0.00433	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	4.61e-05	0.00429	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	4.54e-05	0.00422	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	4.41e-05	0.00411	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	4.31e-05	0.00401	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—AGT—primary biliary cirrhosis	4.29e-05	0.00399	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	4.21e-05	0.00392	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	4.13e-05	0.00384	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	4.08e-05	0.0038	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	3.98e-05	0.0037	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	3.96e-05	0.00369	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	3.93e-05	0.00366	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	3.92e-05	0.00365	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCR5—primary biliary cirrhosis	3.91e-05	0.00364	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	3.91e-05	0.00364	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	3.9e-05	0.00364	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCR5—primary biliary cirrhosis	3.75e-05	0.00349	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	3.75e-05	0.00349	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—LBR—primary biliary cirrhosis	3.67e-05	0.00342	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CXCL10—primary biliary cirrhosis	3.61e-05	0.00336	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL9—primary biliary cirrhosis	3.55e-05	0.00331	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—AGT—primary biliary cirrhosis	3.47e-05	0.00323	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—AGT—primary biliary cirrhosis	3.46e-05	0.00322	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CXCL10—primary biliary cirrhosis	3.45e-05	0.00322	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	3.41e-05	0.00318	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	3.41e-05	0.00318	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL9—primary biliary cirrhosis	3.4e-05	0.00317	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	3.3e-05	0.00307	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	3.27e-05	0.00304	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	3.19e-05	0.00297	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	3.18e-05	0.00296	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	3.15e-05	0.00294	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	3.11e-05	0.00289	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CCL5—primary biliary cirrhosis	3.1e-05	0.00289	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	3.1e-05	0.00288	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—NOS2—primary biliary cirrhosis	2.99e-05	0.00279	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.97e-05	0.00277	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	2.91e-05	0.00271	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	2.9e-05	0.0027	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	2.87e-05	0.00267	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—AGT—primary biliary cirrhosis	2.85e-05	0.00266	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	2.75e-05	0.00256	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	2.74e-05	0.00255	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	2.71e-05	0.00253	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—OGDH—primary biliary cirrhosis	2.66e-05	0.00247	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	2.64e-05	0.00246	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	2.64e-05	0.00246	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCR5—primary biliary cirrhosis	2.63e-05	0.00245	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	2.63e-05	0.00245	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	2.6e-05	0.00243	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	2.6e-05	0.00243	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—AGT—primary biliary cirrhosis	2.6e-05	0.00242	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—AGT—primary biliary cirrhosis	2.49e-05	0.00232	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	2.43e-05	0.00226	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCL10—primary biliary cirrhosis	2.42e-05	0.00226	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDH5—primary biliary cirrhosis	2.4e-05	0.00224	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	2.4e-05	0.00224	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	2.4e-05	0.00223	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL9—primary biliary cirrhosis	2.39e-05	0.00222	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PDHX—primary biliary cirrhosis	2.37e-05	0.00221	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	2.37e-05	0.0022	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	2.32e-05	0.00216	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	2.31e-05	0.00216	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.31e-05	0.00215	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	2.31e-05	0.00215	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDH5—primary biliary cirrhosis	2.3e-05	0.00214	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	2.3e-05	0.00214	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	2.29e-05	0.00213	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	2.27e-05	0.00211	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—DLAT—primary biliary cirrhosis	2.23e-05	0.00207	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCB4—primary biliary cirrhosis	2.23e-05	0.00207	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.21e-05	0.00206	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.1e-05	0.00196	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.09e-05	0.00195	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	2.09e-05	0.00194	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.09e-05	0.00194	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CCL5—primary biliary cirrhosis	2.07e-05	0.00192	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	2.04e-05	0.0019	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.01e-05	0.00187	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.95e-05	0.00182	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.94e-05	0.00181	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.86e-05	0.00173	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.85e-05	0.00172	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.77e-05	0.00165	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.75e-05	0.00163	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—AGT—primary biliary cirrhosis	1.75e-05	0.00163	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—AGT—primary biliary cirrhosis	1.75e-05	0.00163	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—AGT—primary biliary cirrhosis	1.73e-05	0.00161	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.69e-05	0.00157	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.68e-05	0.00156	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDH5—primary biliary cirrhosis	1.62e-05	0.00151	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.62e-05	0.00151	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDH5—primary biliary cirrhosis	1.61e-05	0.0015	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDH5—primary biliary cirrhosis	1.6e-05	0.00149	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.59e-05	0.00148	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCR5—primary biliary cirrhosis	1.56e-05	0.00145	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCR5—primary biliary cirrhosis	1.55e-05	0.00145	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCR5—primary biliary cirrhosis	1.54e-05	0.00143	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.53e-05	0.00142	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.47e-05	0.00137	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.44e-05	0.00134	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL9—primary biliary cirrhosis	1.42e-05	0.00132	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL9—primary biliary cirrhosis	1.41e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.41e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL9—primary biliary cirrhosis	1.4e-05	0.0013	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.37e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.37e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	1.36e-05	0.00126	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NUP210—primary biliary cirrhosis	1.34e-05	0.00125	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AGT—primary biliary cirrhosis	1.33e-05	0.00124	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.31e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.31e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.29e-05	0.0012	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AGT—primary biliary cirrhosis	1.28e-05	0.00119	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.25e-05	0.00116	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.24e-05	0.00116	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCG2—primary biliary cirrhosis	1.24e-05	0.00116	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.23e-05	0.00115	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.18e-05	0.0011	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.18e-05	0.0011	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.17e-05	0.00109	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.14e-05	0.00106	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.13e-05	0.00106	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.12e-05	0.00105	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.09e-05	0.00102	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.07e-05	0.001	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.07e-05	0.000997	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CTGF—primary biliary cirrhosis	1.07e-05	0.000994	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.06e-05	0.000988	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GOT2—primary biliary cirrhosis	1.06e-05	0.000985	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.05e-05	0.000975	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.04e-05	0.000967	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP3—primary biliary cirrhosis	9.97e-06	0.000929	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TYK2—primary biliary cirrhosis	9.97e-06	0.000928	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.9e-06	0.000922	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.86e-06	0.000919	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.77e-06	0.00091	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP3—primary biliary cirrhosis	9.55e-06	0.000889	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TYK2—primary biliary cirrhosis	9.54e-06	0.000889	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL5—primary biliary cirrhosis	9.41e-06	0.000877	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	9.26e-06	0.000862	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GGT1—primary biliary cirrhosis	9.13e-06	0.00085	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GOT1—primary biliary cirrhosis	9.13e-06	0.00085	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	9.12e-06	0.000849	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL5—primary biliary cirrhosis	9.01e-06	0.000839	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AGT—primary biliary cirrhosis	8.99e-06	0.000837	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AGT—primary biliary cirrhosis	8.96e-06	0.000834	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AGT—primary biliary cirrhosis	8.87e-06	0.000826	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	8.73e-06	0.000813	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	8.7e-06	0.000811	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	8.7e-06	0.000811	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARGC1A—primary biliary cirrhosis	8.12e-06	0.000757	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.9e-06	0.000736	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AGT—primary biliary cirrhosis	7.87e-06	0.000733	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.57e-06	0.000705	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AGT—primary biliary cirrhosis	7.54e-06	0.000702	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.37e-06	0.000687	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.35e-06	0.000684	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.28e-06	0.000678	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CD80—primary biliary cirrhosis	6.97e-06	0.00065	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP3—primary biliary cirrhosis	6.72e-06	0.000626	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.72e-06	0.000626	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP3—primary biliary cirrhosis	6.7e-06	0.000624	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.7e-06	0.000624	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CD80—primary biliary cirrhosis	6.68e-06	0.000622	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP3—primary biliary cirrhosis	6.64e-06	0.000618	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.63e-06	0.000618	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL5—primary biliary cirrhosis	6.35e-06	0.000591	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AGT—primary biliary cirrhosis	6.33e-06	0.000589	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL5—primary biliary cirrhosis	6.33e-06	0.000589	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL5—primary biliary cirrhosis	6.26e-06	0.000583	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.15e-06	0.000573	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.13e-06	0.000571	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.07e-06	0.000565	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TYK2—primary biliary cirrhosis	5.89e-06	0.000548	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TYK2—primary biliary cirrhosis	5.64e-06	0.000525	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.33e-06	0.000496	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.31e-06	0.000495	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AGT—primary biliary cirrhosis	5.31e-06	0.000494	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AGT—primary biliary cirrhosis	5.29e-06	0.000493	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.26e-06	0.00049	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AGT—primary biliary cirrhosis	5.24e-06	0.000488	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	5.23e-06	0.000487	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	4.86e-06	0.000453	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—primary biliary cirrhosis	4.86e-06	0.000452	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CD80—primary biliary cirrhosis	4.7e-06	0.000438	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CD80—primary biliary cirrhosis	4.69e-06	0.000437	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CD80—primary biliary cirrhosis	4.64e-06	0.000432	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—primary biliary cirrhosis	4.64e-06	0.000432	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.59e-06	0.000427	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—primary biliary cirrhosis	4.44e-06	0.000414	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.39e-06	0.000409	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	4.17e-06	0.000389	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	4.13e-06	0.000385	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.97e-06	0.00037	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TYK2—primary biliary cirrhosis	3.96e-06	0.000369	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TYK2—primary biliary cirrhosis	3.92e-06	0.000365	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	3.57e-06	0.000332	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	3.57e-06	0.000332	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	3.18e-06	0.000296	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.13e-06	0.000291	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—primary biliary cirrhosis	3.12e-06	0.00029	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.09e-06	0.000288	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—primary biliary cirrhosis	3.09e-06	0.000287	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.08e-06	0.000287	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.05e-06	0.000284	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.47e-06	0.00023	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.9e-06	0.000177	CbGpPWpGaD
